×
Please click
here
if you are not redirected within a few seconds.
All
News
Images
Shopping
Maps
Videos
Books
Search tools
Recent
Recent
Past hour
Past 24 hours
Past week
Past month
Past year
Archives
Sorted by relevance
Sorted by relevance
Sorted by date
Chimerix Releases Updated Corporate Presentation for Investors - TipRanks.com
Tipranks
The latest update is out from Chimerix (CMRX). On May 1, 2024, the Company released an updated corporate presentation for use in discussions...
3 days ago
Chimerix antiviral to be tested in West African Ebola trial
Yahoo News UK
(Reuters) - Chimerix Inc said its experimental broad-spectrum antiviral was one of two agents to be tested in a trial in confirmed Ebola...
17 hours ago
Chimerix (CMRX) Misses Q1 EPS by 4c
StreetInsider
Chimerix (NASDAQ: CMRX) reported Q1 EPS of ($0.25), $0.04 worse than the analyst estimate of ($0.21). Revenue for the quarter came in at...
3 days ago
FY2028 EPS Estimates for Chimerix, Inc. (NASDAQ:CMRX) Decreased by Analyst
Defense World
Chimerix, Inc. (NASDAQ:CMRX – Free Report) – Analysts at Capital One Financial reduced their FY2028 earnings per share estimates for...
21 hours ago
Earnings call: Chimerix reports steady Q1 progress, eyes global expansion
Investing.com
Chimerix Inc . (NASDAQ:CMRX) discussed its first quarter 2024 financial results and operational progress, emphasizing its strategic efforts...
3 days ago
Chimerix (STU:CXF) EPS without NRI : €-0.86 (TTM As of Dec. 2023)
GuruFocus
Chimerix (STU:CXF) EPS without NRI as of today (May 03, 2024) is €-0.86. EPS without NRI explanation, calculation, historical data and more.
1 day ago
Chimerix to Report First Quarter 2024 Financial Results and Provide an Operational Update on ...
Bakersfield.com
DURHAM, N.C., April 24, 2024 (GLOBE NEWSWIRE) -- Chimerix (NASDAQ:CMRX), a biopharmaceutical company whose mission is to develop medicines...
1 week ago
Chimerix: Tackling A Strong Unmet Need With Promising Data (NASDAQ:CMRX)
Seeking Alpha
Chimerix: Tackling A Strong Unmet Need With Promising Data ... Topline Summary. Chimerix, Inc (NASDAQ:CMRX) is a microcap biotech stock focused...
2 months ago
Chimerix, Inc. (NASDAQ:CMRX) Expected to Earn Q1 2025 Earnings of ($0.23) Per Share
Defense World
Read Chimerix, Inc. (NASDAQ:CMRX) Expected to Earn Q1 2025 Earnings of ($0.23) Per Share at Defense World.
22 hours ago
Chimerix reports Q1 EPS (25c), consensus (22c) - TipRanks.com
Tipranks
Patients, caregivers and physicians are in desperate need for novel therapies that offer clinical benefit in H3 K27M-mutant diffuse glioma,...
3 days ago